Vorinostat Recruiting Phase 2 Trials for Colorectal Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02316340Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer